Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
The journey of oleic acid traces back to early soap makers, who stumbled on fatty acids long before the language of “pharma grade” existed. Chemists in the nineteenth century finally isolated and named it, but old records show that olive oil extract, rich in this monounsaturated fat, held a place in medicine and household life for generations. By the time BP, EP, and USP grades entered the scene, the laboratories had moved far from wood-and-glass alchemy to world-class standards, enforcing purity and consistency for use in injectables. This push for quality didn’t happen in a vacuum; the drive came from demand for safer, more reliable excipients in intravenous drugs and nutrition.
Oleic acid in this grade isn’t just olive oil in a bottle. Naming standards—BP for British Pharmacopoeia, EP for European Pharmacopoeia, USP for United States Pharmacopeia—mean the liquid must hit strict benchmarks. Clear to pale yellow, it carries a distinctive fatty aroma. Laboratories monitor everything from heavy metals to residual solvents before a drop touches a sterile syringe.
Most chemical catalogs list oleic acid as a colorless to light yellow oily liquid, melting around 13 to 14°C, and boiling above 360°C. In water, it’s all but insoluble, forming a cloudy mixture, but dissolves easily in ether or ethanol. The acid’s hallmark is its unsaturated carbon chain—one double bond at the ninth carbon, C18:1, making it “mono-unsaturated.” This structure gives the molecule a kink, helping it stay fluid at room temperature.
BP, EP, and USP standards mean inspections go deeper than “does it look clear?” Each batch must hold specific fatty acid ratios, typically over 65 percent oleic acid, low peroxide values, guaranteed absence of harmful residuals, and an acid value within a narrow band. Labeling stays precise: content, grade, batch number, expiration, storage guidance, hazard warnings, and often a “for injection” qualifier sit on every container. This transparency bypasses jargon, allowing users and regulators to know exactly what’s inside.
Traditional soap makers rendered animal or plant fats, separated glycerin, and ended up with rough fatty acids—oleic among them. Modern factories blend hydrolysis with cold and hot pressing, saponification, or distillation. This usually starts with olive, sunflower, or animal fat, splits triglycerides, then washes and purifies the acidic layer. Pharmaceutical plants filter, neutralize, and polish with vacuum distillation, repeatedly washing away contaminants and confirming purity by gas chromatography. One can track the steps from harvest to injection with a microscope, not just a microscope but layers of digital traceability.
Chemists often reach for oleic acid in labs thanks to that reactive double bond and carboxylic acid. Hydrogenation transforms it into stearic acid, making candles or tablets stiffer. Esterification links it to alcohols, building surfactants for pharma or food. That unsaturated bond can open doors—oxidation or epoxidation creates building blocks for vitamin synthesis, surfactants, even flexible plastics. Even in injections, some research explores tweaks in structure to carry drugs deeper into cells.
Oleic acid goes by many names, depending on who’s asking. Latin plant labels (cis-9-octadecenoic acid), trade names (Red Oil, Elaidic Acid—trans form), and strict compound codes appear across patents, pharmacopeia entries, and shipping manifests. “For injection, BP EP USP” marks the top shelf in terms of scrutiny. Choosing the right label helps avoid confusion that could turn a sterile formula into a hazardous mistake.
Labs and manufacturers follow tough rules by habit, not just regulation. Oleic acid in pharma plants gets handled with gloves, eye shields, and air systems that vacuum away vapors. Storage tanks sit at stable, cool temperatures to keep oxidation at bay—nobody wants a rancid batch anywhere near an IV bag. Batch-after-batch testing for heavy metals, endotoxins, and microbiological threats supports the supply of sterile injections. Workers watch for skin or eye contact, since even high-purity oleic acid carries irritant risks.
While oleic acid’s culinary ties run deep—think olive oil in the Mediterranean diet—its role in injectable medicine stands apart. Hospitals rely on it as an emulsifying agent in parenteral nutrition, especially for patients on long-term IV feeding, since the body can process it as an energy source. Formulators use it in drug delivery to help dissolve tricky, poorly water-soluble drugs, improving absorption. Surfactant roles don't stop there; research explores its activity in vaccines and gene therapy carriers. The biotech boom guarantees more uses on the horizon, but the injectable grades remain a staple for safety-driven manufacturing.
Investments in R&D upend old ideas about “just a fatty acid.” Clinical researchers have tested oleic acid derivatives for anti-inflammatory actions, cancer-targeting, and gene therapy vectors. Chemists adjust fatty acid lengths and saturation, aiming for new carriers that slip through cell walls better. Collaborations between universities and pharmaceutical companies feed a steady drip of studies—open-label, double-blind, and everything in between. Labs test formulations for stability, patient outcomes, and economic viability, not content to treat oleic acid as a background ingredient.
Most people consume oleic acid every day in food, but injections bypass the gut’s filtering. Experts have dug into the details: animal studies help determine dose thresholds, warning signs, and allergic reactions. At high concentrations, free fatty acids can disrupt cell membranes, so dosing gets careful calculation. The strict BP/EP/USP standards stem in part from these safety datalines. In practice, hospitals and research centers escalate usage slowly, watching for adverse events. Existing therapies show good safety at prescribed levels, but nobody loses sight of potential side effects—especially as new uses emerge.
Next-generation medicine keeps finding jobs for molecules once considered simple fats. Delivery systems chase boosted bioavailability, targeting molecules, and minimal side effects. Some researchers even look at combining oleic acid with biologics or nanomedicines for custom therapies. With global health systems leaning on injectable nutrition for sicker, older patient groups, and drug companies racing to solve solubility gaps, the high-purity fatty acid market faces fresh demand. Sustainability shapes sourcing decisions, prompting interest in renewable, traceable plant sources—a shift that echoes back to historic olive groves but rides the wave of biotechnology and green chemistry.
Oleic acid may sound technical, but it’s just a natural fatty acid found in olive oil, animal fats, and even our own bodies. People notice it in cooking oils, but this same ingredient, in pharmaceutical-grade quality, finds a much greater calling in the medical world. Quality matters in medicine; that’s why pharma-grade oleic acid, produced under strict BP, EP, and USP standards, enters the scene for injectable products.
Drug manufacturers use this ingredient to make some tricky medications deliver their healing powers effectively. Many drugs dissolve poorly in water. To give patients these medicines in a shot or infusion, pharmacists blend the active ingredient with something that helps it stay mixed and stable—this is where oleic acid steps in.
Take certain cancer drugs, vaccines, or antibiotics. Some of these rely on fat-based carriers to move the medicine through the bloodstream safely and get it to the right spot. Oleic acid acts like a vehicle that carries these drugs, helping them dissolve so your body can put them to work. Without ingredients like this, doctors would face a narrow range of drugs they could give by injection.
Oleic acid for medical use isn’t just lifted from kitchen oils. Manufacturers need purity. Impurities can trigger allergic reactions or even poison patients—no small risk when injections skip the body’s usual defenses. Pharmaceutical standards such as BP (British Pharmacopoeia), EP (European Pharmacopoeia), and USP (United States Pharmacopeia) put strict limits on what’s allowed into the bottle. Each batch must stand up to repeated scrutiny. A batch that fails can’t go into a medicine, not even in trace amounts.
Working in a pharmacy, I’ve watched how supply shortages hit hospitals. Chemists and compounding pharmacists double-check paperwork, not trusting any ingredient blindly. If something slips, it’s patients who pay. Maintaining a steady source of pure, reliable oleic acid helps everyone up and down the chain—from doctors and pharmacists to kids in pediatric wards who might need medicine only available as an injection.
Pharma-grade oleic acid isn’t meant for self-experimentation. Side effects remain low when used properly and mixed with trained precision, but mixing errors or bad-quality inputs turn a useful medicine into a risk. Regulatory bodies watch these supplies closely. Serious side effects get reported, tracked, and investigated. Every vial shipped for use in hospitals stands on a foundation of daily, behind-the-scenes diligence.
Even as scientists keep oleic acid safe and effective for injections, research keeps moving forward. New delivery systems, like lipid nanoparticles, help deliver RNA vaccines—technology that famously enabled COVID-19 shots. These methods often rely on specialized fats, sometimes using forms of oleic acid, to create protective “bubbles” around delicate medicine molecules.
Strong attention to the source, chemistry, and storage of oleic acid pays off. The more we support regulated supply chains, invest in quality control, and promote open research, the more likely patients everywhere continue to receive safe, life-saving treatment when it matters most.
Not all oleic acid stands on equal footing. Pharmacies and drug manufacturers count on a steady supply of this monounsaturated fatty acid because the risks of impurities go far beyond a failed batch. Every milligram matters, especially for injectable formulations or sensitive oral drugs. Impurities—such as stearic acid, palmitic acid, or leftover catalysts—can turn a safe ingredient into a trigger for inflammation, allergic reactions, or inconsistent drug dissolution. So, manufacturers and pharmacists look deeper than a clear liquid—they demand proof behind the label.
Pharmaceutical-grade oleic acid walks a very straight line. Purity needs to reach at least 99%, often documented on a certificate of analysis. Any trace of related fatty acids, peroxide values, moisture, and other contaminants has to fall underneath globally recognized thresholds—sometimes as tight as 0.1% or even lower for certain substances. Regulatory bodies like the United States Pharmacopeia (USP) and the European Pharmacopoeia (Ph. Eur.) hand down clear specs, including:
In my experience as a pharmacy technician and coursework grounded in pharmacology, the strictness of these limits helps avoid unnecessary recalls and side effects. No shortcut replaces a clean supply chain.
Meeting these fine-tuned benchmarks matters most for those who never read the ingredient label. Physicians trust that the injectable medications or ointments they prescribe contain only what's necessary. For children with cystic fibrosis, for instance, even a tiny trace of impurity in an emulsion or suspension can tip the scales from safe to dangerous. Families with severe allergies can only trust a product if every production stage blocks cross-contamination. Every lab I’ve known approaches each test result as a safeguard, not a formality.
Better quality starts with traceable raw materials, as impurities often sneak in from the initial feedstock. Supplier relationships built on transparency, robust auditing, and regular testing reduce risk. Some plants refine their filtration and purification steps using high-vacuum distillation, driving away lingering contaminants. Labs keep updating testing technology—switching from old-school wet chemistry to chromatographic and spectrometric tools that pick up even tiny flaws in the fatty acid profile.
Regulatory agencies keep fine-tuning specifications. New guidelines on nitrosamine testing, for example, push companies to screen for emerging contaminants. As therapies get more personalized—think injectable biologics or microemulsions—the tolerance for any slip drops even lower.
Meeting these standards demands time, investment, and a sharp ethical focus. In the end, the payoff isn’t measured by raw purity but by confidence in each dose delivered from factory to pharmacy shelf.
Most folks come across oleic acid in daily cooking oils—olive oil gets its reputation from being packed with it. Pharmaceutical labs see it differently. This fatty acid sometimes works as a solvent or an excipient, playing a supporting role in capsules or topical applications. People often ask whether it’s fine to carry that same ingredient into shots that go straight into a vein.
Injecting a substance into the bloodstream isn’t the same as eating or rubbing it on the skin. The gut can tolerate things the veins cannot. Doctors and pharmacists decide on each material’s safety based on what happens inside the body—both immediately and over time. Oleic acid is a fatty acid. Most dietary intake gets absorbed and processed in the intestines and liver, not directly in blood. If one injects it, the acid ends up in direct contact with blood cells and blood vessel walls. That’s a far cry from its usual journey through the digestive system.
Scientists have good reasons for being picky. Human trials and animal studies actually show that shooting oleic acid straight into the blood causes some trouble. Even a moderate dose can produce lung problems or blood clots. As a pharmacist who has worked in hospital settings, I’ve seen risky excipients lead to real consequences, such as embolism or inflammation, when someone chose the wrong material for an intravenous formula. These aren’t just academic concerns—patients can end up with severe breathing problems or even organ failure. Reports and case studies going back decades confirm this risk, especially among people with weaker health to begin with.
Drug manufacturers check all excipients against global standards set by regulators like the US FDA or the European Pharmacopeia. For anything destined for IV use, that list tightens up. Oleic acid approved for these uses sits in a class of its own; it’s been handled, cleaned, and purified beyond what’s used in the food industry. That extra work means no pesticides, heavy metals, or fungal toxins should sneak through. If a supplier can’t guarantee this purity, hospitals shouldn’t touch the material for intravenous products. The wrong impurity, a little too much peroxide, or a poor manufacturing process means serious risks for patients already in fragile condition.
Many products designed for parenteral use rely on other fats, like medium-chain triglycerides or refined soybean and safflower oil, with long safety records. These serve as carriers that don’t bring the same risks seen with raw or poorly purified oleic acid. In my experience, working with hospital pharmacists and industry scientists, the best outcome comes from picking ingredients already proven in clinical trials, not just what seems safe on paper or in oral products. If a new version of oleic acid claims to be suitable for IV use, it must come with strong evidence from real-world research and official certifications. That’s how patients stay safe, and how progress moves forward without cutting corners.
Oleic acid marks its territory in the pharmaceutical world, especially for formulations used in parenteral nutrition and as an excipient for injectable drugs. The way it's packaged matters, not just for logistics but also for safety, quality, and compliance. Over years spent around sterile manufacturing, I’ve seen oleic acid land in several different-sized containers. Most suppliers offer it in options such as 1-liter amber glass bottles, 2.5-liter plastic drums, and larger 5-liter or 25-liter HDPE carboys for bulk use. At times, smaller 100 ml or 500 ml glass containers come into play, typically for lab batches or low-volume hospital compounding. These aren’t random numbers; regulatory bodies call for packaging that limits contamination and light exposure.
Bulk sizes go to big compounders and pharmaceutical plants, where volumes justify it. Smaller bottles wind up with pharmacies and R&D centers. You’ll rarely see oleic acid for injection sitting in anything other than tight-sealing, tamper-proof containers. Any manufacturer staking a claim on quality isn’t going to risk leaky closures, as even minor oxidation or moisture seeps can ruin the product. If you’re ever curious, amber glass gets top marks here because it fends off light, especially ultraviolet, which tends to degrade fats over time.
Oleic acid’s reputation for stability only holds up under the right storage. Temperature swings, sloppy sealing, and bad handling have ruined more than a few batches I’ve come across. Standard good practice means storing it at 20–25°C. Manufacturers routinely recommend a range, never above 30°C, as higher warmth accelerates rancidity and changes the acid’s integrity. Anything below 15°C risks thickening or even solidifying the liquid, which makes it tough to draw for injection.
Keeping stock away from direct sunlight and heat sources shouldn't feel like rocket science, but it happens more than you’d think. Lights in storerooms or sun from a window can start a slow decline in quality. Venturing into older facilities, I’ve found that a bit of extra vigilance—a clean, dry cabinet with stable temperature—matters a lot. Moisture also poses a threat. Humid environments create the perfect storm for hydrolysis, opening the door to breakdown and possible contamination.
There’s a level of discipline expected here—pharmacies, hospitals, and manufacturers keep logs of delivery dates, check temperature settings, and run checks on container integrity. According to FDA and European Medicines Agency guidelines, the shelf life shrinks dramatically if stock breaks from the recommended temperature, even for a few hours. In practice, many facilities keep digital thermometers with alarms and restrict access to trained staff.
Any switch in supplier, container material, or storage protocol calls for new risk assessments and stability testing. Years ago, a facility swapped plastic for glass containers and failed to adjust storage conditions; product recall soon followed. These lessons shape policies across industries today.
Some suppliers now fit tamper indicators and batch-level barcoding on every carboy or bottle, making tracking and traceability easier. Smart temperature-logging devices link with inventory software so managers get warnings before storage conditions drift. Training for pharmacy staff now covers storage audits as part of regular inspections. It’s not just box-ticking. The lives of patients depend on strict routines around handling and storage—the tiniest slip can mean a rejected batch or much worse.
The facts stay simple: consistent packaging standards and controlled storage conditions safeguard oleic acid for injection, from plant to patient. That isn’t changing anytime soon.
When I scroll through online stores or browse products claiming purity or health benefits, I rarely see customers asking about a Certificate of Analysis (COA) up front. Yet, this document changes the whole equation. A COA is not just an extra file for company archives. It confirms through third-party lab results what’s actually inside the package. Think of it as the nutritional label for chemical and supplement products, except verified outside the company. If a protein powder says it contains no heavy metals, or if a supplement claims 99% purity, the COA is the proof customers need to trust that statement.
Having spent years watching product recalls unfold and listening to worried customers, I know false or missing information on product purity sparks real trouble. In 2019, tainted supplements led to hospitalizations in several states. Customers deserve to explore products with real information on what’s inside, not just marketing claims. Labs performing these tests face audits, sometimes every few months, making results far more reliable than one-off internal test sheets.
It’s easy to get lost in fancy packaging or buzzwords, but Good Manufacturing Practices (GMP) separate careless operations from those who prioritize safety. GMP certification shows a company is audited on how it handles materials, cleanliness, manufacturing steps, and even documentation. A facility could buy high-quality raw materials, but if workers don’t follow proper hygiene, or machinery remains dirty between batches, the end product may pick up unwanted contaminants.
Big brands in food, supplements, and cosmetics—think Nestlé, GNC, or even drugstores—won’t take on a new supplier unless paperwork proves GMP is followed. It’s not about legal shielding; these companies know the risks if their customers lose trust or fall ill. In my own work choosing suppliers, a missing GMP certificate sends me looking elsewhere. It’s become a shorthand for basic quality and accountability, not just a luxury for rich companies.
One of the most talked-about issues in the supplement market is fake or mislabeled products. In the US, the FDA has published warning letters to companies for selling supplements that contain dangerous stimulants instead of ingredients listed on the label. Those firms had no COA or faked their documents. There’s a reason news headlines about contaminated or misleading products keep popping up: shortcuts happen where oversight is weak or buyers don’t ask questions.
People think they can tell good from bad just by looking. I’ve witnessed dozens of products with perfect, professional-looking bottles that tested dirty or weakened under scrutiny. When companies display real, up-to-date COA and GMP certificates—preferably with lot numbers matching the package—customers can feel more at ease. For business buyers, especially those making products for export, failing to secure these documents means shipments held up in customs, fines, or complete product recalls.
Customers asking about COA and GMP create change faster than new laws. When phone lines and inboxes fill with questions about certification, sellers step up or lose business. Retailers such as Amazon now require third-party test reports for some supplement listings, a move sparked by consumer demand. Pharmacies and food service giants also regularly audit suppliers, not just accepting the lowest price or best sales pitch.
Anyone buying or selling products should treat certification as non-negotiable. Requesting to see a COA and GMP certification is like reading reviews before booking a hotel. If the business dismisses the request or hesitates, that speaks louder than any claim on the label. Real transparency and consistent testing keep people safe and honest, plain and simple.
| Names | |
| Preferred IUPAC name | (Z)-Octadec-9-enoic acid |
| Other names |
cis-9-Octadecenoic acid 9-Octadecenoic acid Red oil C18:1 Etholeic acid |
| Pronunciation | /ˈoʊ.li.ɪk ˈæs.ɪd/ |
| Identifiers | |
| CAS Number | 112-80-1 |
| 3D model (JSmol) | `CCCCCCCC=CCCCCCCCC(=O)O` |
| Beilstein Reference | 1721924 |
| ChEBI | CHEBI:36444 |
| ChEMBL | CHEMBL1429864 |
| ChemSpider | 5284440 |
| DrugBank | DB04224 |
| ECHA InfoCard | ECHA InfoCard: 100.003.467 |
| EC Number | 200-368-9 |
| Gmelin Reference | Gmelin Reference: 21240 |
| KEGG | C00712 |
| MeSH | D017866 |
| PubChem CID | 445639 |
| RTECS number | RG3320000 |
| UNII | 1959453Y2B |
| UN number | UN 3265 |
| CompTox Dashboard (EPA) | DTXSID7020828 |
| Properties | |
| Chemical formula | C18H34O2 |
| Molar mass | 282.47 g/mol |
| Appearance | Clear, colorless to pale yellow oily liquid |
| Odor | Characteristic odor |
| Density | 0.89 g/cm³ |
| Solubility in water | Insoluble in water |
| log P | logP = "7.64 |
| Vapor pressure | <0.01 mmHg (@20°C)> |
| Acidity (pKa) | pKa ≈ 9.85 |
| Basicity (pKb) | pKb: 15.6 |
| Refractive index (nD) | 1.453—1.457 |
| Viscosity | Viscosity: 28–56 cP (at 25°C) |
| Dipole moment | 1.327 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 206.0 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -365.0 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | –12,155 kJ·mol⁻¹ |
| Pharmacology | |
| ATC code | A01AD11 |
| Hazards | |
| Main hazards | Harmful if swallowed, causes skin and eye irritation, may cause respiratory irritation. |
| GHS labelling | GHS02, GHS07, Danger, H226, H315, H319, P210, P280, P305+P351+P338, P337+P313 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | No hazard statement. |
| Precautionary statements | Keep container tightly closed. Store in a cool, dry, and well-ventilated area. Use personal protective equipment as required. Avoid breathing dust, fume, gas, mist, vapours, or spray. Wash hands thoroughly after handling. |
| NFPA 704 (fire diamond) | NFPA 704: 1-1-0 |
| Flash point | 185 °C |
| Autoignition temperature | 335°C |
| Lethal dose or concentration | LD₅₀ (oral, rat): >74,000 mg/kg |
| LD50 (median dose) | LD50 (median dose): Rat oral >50 g/kg |
| NIOSH | Not established |
| PEL (Permissible) | PEL: 5 mg/m³ |
| REL (Recommended) | 3 mg/m³ |
| Related compounds | |
| Related compounds |
Elaidic acid Linoleic acid Stearic acid Palmitic acid Myristic acid |
Chengguan District, Lanzhou, Gansu, China
